Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Suzanne N. Voorrips"'
Autor:
Suzanne N Voorrips, B Daan Westenbrink
Publikováno v:
European Heart Journal. 44:1647-1649
Autor:
Kirsten T. Nijholt, Pablo I. Sánchez‐Aguilera, Suzanne N. Voorrips, Rudolf A. de Boer, B. Daan Westenbrink
Publikováno v:
European Journal of Heart Failure. 24(2):287-298
Impaired exercise capacity is the key symptom of heart failure (HF) and is associated with reduced quality of life and higher mortality rates. Unfortunately, current therapies, although generally lifesaving, have only small or marginal effects on exe
Autor:
Huitzilihuitl Saucedo-Orozco, Suzanne N. Voorrips, Salva R. Yurista, Rudolf A. de Boer, B. Daan Westenbrink
Publikováno v:
Journal of Lipid and Atherosclerosis
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as powerful drugs that can be used to treat heart failure (HF) patients, both with preserved and reduced ejection fraction and in the presence or absence of type 2 diabetes. While the mec
Autor:
Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink
Publikováno v:
International Journal of Molecular Sciences, 23(15):8631. MDPI AG
Despite the constant improvement of therapeutical options, heart failure (HF) remains associated with high mortality and morbidity. While new developments in guideline-recommended therapies can prolong survival and postpone HF hospitalizations, impai